Document is current
Any future updates will be listed below
-
Authors
Baatallah, Nesrine
Elbahnsi, Ahmad
Mornon, Jean-Paul
Chevalier, Benoit
Pranke, Iwona
Servel, Nathalie
Zelli, Renaud
Décout, Jean-Luc
Edelman, Aleksander
Sermet-Gaudelus, Isabelle
Callebaut, Isabelle
Hinzpeter, Alexandre https://orcid.org/0000-0001-6920-7761
-
Funding
Funding for this research was provided by:
association vaincre la mucoviscidose (RF20170502018)
grand équipement national de calcul intensif (2017-A0020707206, 2018-A0040707206, 2019-A0060707206, 2020-A0080707206)
- License Information
-
More Information
Article History
Received: 6 July 2021
Revised: 11 October 2021
Accepted: 15 October 2021
First Online: 29 October 2021
Declarations
:
: NB, AhE, JPM, BC, IP, NS, RZ, JLD, AlE, IC, and AH declare no competing interests. ISG reports grants from Vertex Therapeutics, Eloxx Pharmaceuticals and participation in the scientific board of Proteostasis Therapeutics; outside the submitted work.
: Not applicable.
: Not applicable.
: Not applicable.
